(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 7. The dfer gain-of-function mutant disrupts axon guidance at the
ventral midline of the CNS. (A,B) Fillets of stage 16
embryos immunostained on the same slide show significantly higher levels of
DFer protein in the CNS of dfergof mutants (B) than in
wild type (A). (C) DFer protein is not expressed in the CNS of
dfer
ex1 mutant embryos.
(D) In wild-type embryos, Fasciclin 2 (brown) is expressed on
longitudinal axons. (E,F) In dfergof
mutants, axons cross the midline aberrantly (E, arrowhead), a phenotype that
is enhanced when the levels of DFerRB are increased (F, arrowheads;
UAS-DFerRB/+;+;dfergof). (G) Expression of
the JNK inhibitor Puc rescues the midline phenotype of
dfergof mutants
(UAS-Puc,dfergof/dfergof).